EyePoint Pharmaceuticals Reports Second Quarter 2022 Financial Results and Highlights Recent Corporate Developments

Go back to EyePoint Pharmaceuticals Reports Second Quarter 2022 Financial Results and Highlights Recent Corporate Developments
(NASDAQ: EYPT) Delayed: 3.93 -0.06 (1.5%)
Previous Close $3.99    52 Week High
Open $3.95    52 Week Low
Day High $3.98    P/E N/A 
Day Low $3.77    EPS
Volume 819,927